DOSING & TITRATION
Missed Doses, Plateaus, and Stopping — GLP-1 Questions After the First Months
By G1 Peptides · Medically reviewed by the G1 Peptides clinical team · Updated September 24, 2026 · 2 min read
THE SHORT ANSWER
A missed weekly dose can be taken late within a few days; otherwise skip it and resume, never double. Plateaus are expected somewhere between months nine and fifteen and are usually the drug's effect reaching equilibrium, not failure. Stopping returns appetite to baseline, so maintenance — on a lower dose or with a taper — is a plan to make with your provider, not an event.
Missed doses
The weekly drugs have half-lives of five to seven days, so a dose taken a few days late still overlaps the previous one.
- Semaglutide: if the next scheduled dose is more than two days away, take the missed dose as soon as you remember; if less than two days away, skip it (FDA label).
- Tirzepatide: take within four days of the missed dose; otherwise skip.
- Retatrutide: similar to tirzepatide — within about three to four days; otherwise skip.
Never take two doses within a couple of days of each other to "catch up." After a gap of two weeks or more, ask your provider whether to restart at a lower step — the gut loses its adaptation quickly and the full dose can bring the escalation-phase nausea back at once.
Changing your injection day
You can shift the day as long as at least two or three days separate doses. Moving from Monday to Friday, for example, means one interval of eleven days — fine — then weekly on Fridays.
Plateaus
Every trial curve flattens, typically between months nine and fifteen. This is expected: the drug reduces intake to a new, lower level, and the body settles at the weight that level supports. A plateau is equilibrium, not resistance.
What to check before deciding anything:
- Intake has crept up. The most common cause. Appetite suppression is still present but less novel, and portions drift. Two weeks of honest tracking usually shows it.
- Protein and training. A plateau on the scale with rising strength may be muscle being retained while fat still falls — a good plateau.
- Dose. If you are on an intermediate step, there is room to escalate. If you are on the maximum, the drug has done what it does.
- Sleep, alcohol, and stress. All three move the equilibrium.
Options a provider might raise: holding the current weight and consolidating habits for a few months; a modest escalation; switching compound (someone who plateaued on semaglutide may lose more on tirzepatide or retatrutide); or accepting the result if it has met the goal.
Stopping and maintenance
Trials that withdrew semaglutide saw about two-thirds of the lost weight regained within a year. The drug was doing the work of a signal your body does not make enough of on its own; when it stops, the old signal returns. That is not a reason never to stop, but it is a reason to plan.
Approaches used in practice:
- Maintenance dosing — staying on a lower dose (often the step below the one you lost weight on) indefinitely, which holds most of the result.
- Tapering — stepping down one dose level every four to eight weeks while building the habits that will need to carry the weight alone.
- Stopping with a plan — for people who have built strong training and nutrition routines and prefer to see what holds, with a low threshold to restart.
Back to the GLP-1 guide.
FREQUENTLY ASKED
I missed two weeks. Can I just take my usual dose?
Ask your provider. After a gap of two weeks or more, nausea is much more likely at the full dose, and many providers restart one step lower and re-escalate.
Can I take the injection every two weeks to save money?
The drugs are designed for weekly dosing; blood levels fall substantially by day 10–14 and appetite returns. Stretching the interval mostly produces a cycle of side effects and hunger. A lower weekly dose is a better economy.
Is it safe to stop suddenly?
There is no withdrawal syndrome; stopping abruptly is not dangerous. The issue is that appetite returns and weight tends to regain, which is why a taper or a maintenance dose is discussed rather than an abrupt stop.
This article is educational and is not medical advice. Peptides are prescription medications; whether any of them is appropriate for you is a decision for a licensed provider who knows your history.